A recent study conducted by UCLA Health Jonsson Comprehensive Cancer Center researchers found that new, non-invasive imaging ...

UCLA researchers developed a non-invasive imaging method using 89Zr-TLX250 to detect clear-cell renal cell carcinoma. This ...

A recent study conducted by UCLA Health Jonsson Comprehensive Cancer Center researchers found that new, non-invasive imaging ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center have demonstrated in a recent study that their novel non ...

HAYWARD, CA, USA I October 02, 2024 I Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing ...

Opdivo’s approval for patients with resectable non-small cell lung cancer comes as the regulator recently raised concerns of ...

CA-NINE’ [2] – led by Professor Brian Shuch at University of California, Los Angeles ( UCLA) – is a Phase II prospective, ...

Kineta, Inc. (OTC Pink: KANT) , a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today that its ...

The approval came days before the FDA’s expected deadline and makes this the only PD-1 inhibitor approved for resectable ...

Estrogens Play a Hidden Role in Cancers, Inhibiting a Key Immune Cell Sep. 27 ... chance of developing head and neck squamous cell carcinoma ... Metabolic Reprogramming of T Cells May Enhance ...

Taking into account the growing importance of co-operation among specialists of different areas, resulting in certified tumor boards in many centers, these kinds of meetings will, in the future ...

Blasts Shake Beirut as Israel Targets Hezbollah Leaders, Officials Say Israeli officials said planes bombed a bunker where senior Hezbollah officials were meeting, including the presumed successor ...